Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Distinctive structural and functional MRI footprint for cognitive dysfunction in pediatric MS?
Strategies for myelin regeneration: lessons learned from development.
Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis.
Treatment of facial myokymia in multiple sclerosis with botulinum toxin.
Can smoking aggravate my multiple sclerosis symptoms?
Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells.
Biomarkers in multiple sclerosis.
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development.
Accentia Biopharmaceuticals Announces that Revimmune Autoimmune Disease Therapy is Featured in Peer-review Journal
Acute reversible periependymal ventricular enhancement in neuromyelitis optica.
Simvastatin in acute optic neuritis.
Early pathological alterations of lower lumbar cords detected by ultrahigh-field MRI in a mouse multiple sclerosis model.
Efficacy of minocycline in acute ischemic stroke: a single-blinded, placebo-controlled trial.
Effects of Dalfampridine Extended-Release Tablets on 6-Minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-Blind, Placebo-Controlled Trial.
Accuracy of StepWatch™ and ActiGraph Accelerometers for Measuring Steps Taken among Persons with Multiple Sclerosis.
The attributable burden of panic disorder in the impairment of quality of life in a national survey in Italy.
Cyclophosphamide for multiple sclerosis.
Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function.
Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells.
Assessing walking disability in multiple sclerosis.
Laquinimod Halted MS Disability But Not Relapses
Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis.
Coping Strategies in Multiple Sclerosis Patients with Frontal Cognitive Disorders.
Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, th17- and activated B-cells and correlates with progression.

Pages